Home / Resource Library / Patient-reported outcomes and quality of life over time in relapsed/refractory diffuse B-cell lymphoma (DLBCL) patients treated with CAR T-cells therapy in clinical practice
Patient-reported outcomes and quality of life over time in relapsed/refractory diffuse B-cell lymphoma (DLBCL) patients treated with CAR T-cells therapy in clinical practice